Aesica’s full-service, end-to-end pharmaceutical development, manufacturing and packaging offering gives us an impressive capability in formulation development for both Active Pharmaceutical Ingredient (API) and finished dose. While Bespak’s strengths lie in world-class device development and manufacturing, and expertise in inhaled and injectable devices, all the way from device design to industrialisation.
Together, they complement each other perfectly. It streamlines and accelerates our pharmaceutical customers’ drug route to market. We believe that having total visibility of this end-to-end service is somewhat unique in our business. It allows our colleagues to see the full production picture and with it the wide range of opportunities open to them.